Compare GRWG & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRWG | ANIX |
|---|---|---|
| Founded | 2008 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.2M | 104.0M |
| IPO Year | 2015 | 2013 |
| Metric | GRWG | ANIX |
|---|---|---|
| Price | $1.12 | $3.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $2.50 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 349.3K | 164.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.82 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $193,365,479.00 | $210,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 142.51 | N/A |
| 52 Week Low | $0.83 | $2.33 |
| 52 Week High | $2.40 | $5.46 |
| Indicator | GRWG | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 31.78 | 43.56 |
| Support Level | $0.95 | $2.69 |
| Resistance Level | $1.21 | $3.00 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 8.33 | 53.75 |
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.